The Impact of Clinic-level Financial Incentives on HPV Vaccine Communication and Uptake
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- HPV vaccination (≥1 dose), 9-12 year olds
研究概览
简要总结
This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
详细描述
The researchers will conduct a cluster randomized control trial. This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. The recruitment goal for the trial is 34 clinics in healthcare systems, including 9 rural-serving clinics. The researchers will randomize clinics using simple randomization (1:1). Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake. The researchers will use medical record data to compare changes in HPV vaccination among children ages 9-12. Clinics will be followed for 24 months. The study will engage clinical staff. Researchers will not have direct contact with children or their families.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 9 Years 至 12 Years（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •This trial will enroll clinics and intervene with clinical staff. We will use vaccination data from children to evaluate intervention effectiveness. We will not enroll children or interact with them directly.
- •Inclusion Criteria:
- •Clinics are eligible if they are a pediatric or family medicine clinic in North Carolina that in the past year had:
- •less than 72% HPV vaccine initiation rate,
- •greater than or equal to 50 patients ages 9-12
- •greater than or equal to 2 HPV vaccine providers
- •no clinic or provider-level financial incentive programs to increase system, clinic, or provider HPV vaccination rates among patients aged 9-12 in the past two years, and
- •no HPV vaccine provider communication trainings in the past six months.
- •Children's medical records will be eligible to be included in the dataset if children:
- •are between the ages of 9-12 years at baseline and
- •are attributed to a participating clinic at 12- or 24-month follow-up.
排除标准
- •Clinics are excluded if they:
- •do not provide HPV vaccine to children ages 9-12
- •have a specialty other than pediatrics or family medicine
- •had an HPV vaccine-specific financial incentive program in the past two years
- •had a formal HPV vaccine communication training in the past 6 months
- •had an HPV initiation rate greater than 72$
- •had fewer than 49 patients aged 9-12
- •had 1 or fewer HPV vaccine providers
- •Children's medical records will not be eligible to be included in the dataset if children:
- •are not between the ages of 9-12 years at baseline
- •are not attributed to a participating clinic at 12- or 24-month follow-up
研究组 & 干预措施
HPV vaccine communication training.
Staff in clinics randomized to this arm will receive an intervention called Announcement Approach Training (AAT). This training is designed to improve communication about HPV vaccination.
干预措施: Communication training (Behavioral)
HPV vaccine communication training and clinic-level financial incentive program
Staff in clinics randomized to this arm will receive the Announcement Approach Training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
干预措施: Communication training (Behavioral)
HPV vaccine communication training and clinic-level financial incentive program
Staff in clinics randomized to this arm will receive the Announcement Approach Training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
干预措施: financial Incentive (Behavioral)
结局指标
主要结局
HPV vaccination (≥1 dose), 9-12 year olds
时间窗: from baseline to 12 months
Proportion of unvaccinated children who initiate the HPV vaccine series between baseline and 12-month follow-up, among those who were ages 9-12 at baseline.
次要结局
- HPV vaccination (≥1 dose), 9-12 year olds(from 13 months to 24 months)
- HPV vaccination (≥2 doses), 9-12 year olds(from 13 months to 24 months)
- HPV vaccination (≥2 doses), 9-12 year olds(from baseline to 12 months)